Evidence map›Paper›PMID 40159879›Full record

ArticleHuman vaccines & immunotherapeutics2025

Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024.

Chaoyan Shen, Juan Zhang, Guanyu Zhang, Hao Luo, Shuangke Zhang, Quan Yuan, Wei Xu, Wei Wang, Lele Miao

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chaoyan ShenDepartment of Ultrasound, Jining NO.1 People's Hospital, Jining, China.
Juan ZhangDepartment of Hematology, Jining NO.1 people' Hospital, Jining, China.
Guanyu ZhangDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Hao LuoDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Shuangke ZhangDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Quan YuanDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Wei XuDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Wei WangDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.
Lele MiaoDepartment of Thyroid and Breast Surgery, Jining NO.1 people' Hospital, Jining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, immune checkpoint inhibitors (ICIs) have emerged as a novel immunotherapeutic approach, offering renewed hope for enhancing cervical cancer patient prognosis. This study represents the inaugural bibliometric analysis of ICIs in the context of cervical cancer, covering the period from 2014 to 2024. A total of 422 articles were identified through the Web of Science Core Collection database, amassing 10,977 citations, with a consistent annual increase in the number of publications. The leading contributors in terms of countries, institutions, journals, and authors included China, the University of Texas System,

Indexed as

BibliometricsBiomedical ResearchImmune Checkpoint InhibitorsUterine Cervical NeoplasmsFemaleHumansImmunotherapyImmune Checkpoint Inhibitorsbibliometriccervical canceremerging topicshotspotsImmune checkpoint inhibitorsvisualization

Identifiers

PMID40159879
PMCPMC11959921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.